MedPath

The effect of transexamic acid and medroxyprogestrone on puerperal bleeding

Not Applicable
Conditions
puerperal bleeding.
complications of the the puerperium unspecified
Registration Number
IRCT201306193461N6
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
66
Inclusion Criteria

Inclusion criterias: women 15-45 ages with prolonged puerperal bleeding; dizziness; hypotension; skin allergy because of tampone use;and 30 days after delivery.
Exclusion critreias: Birth canal lacerations; retained placenta; myoma and endometrial polyps; history of chronic diseases such as: hepatic, renal,diabetes, thromboembolic and coagulative disorders; anticoagulative drug use ; and thrombocytopenia.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The volume of bleeding. Timepoint: Before and six weeks after intervention. Method of measurement: The number of used pads before and after intervention.;Hb level. Timepoint: Before and six weeks after intervention. Method of measurement: Hb level measurement.
Secondary Outcome Measures
NameTimeMethod
Headache and dizziness. Timepoint: Before and six weeks after intervention. Method of measurement: Patient report.;Spotting. Timepoint: Before and six weeks after intervention. Method of measurement: Patient report.;Repeat intervention. Timepoint: Up to six weeks after intervention. Method of measurement: Surgery,D&C,administration of drug.
© Copyright 2025. All Rights Reserved by MedPath